Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Maya Levi"'
Autor:
Arpad Szoor, Gyorgy Vereb, Orit Itzhaki, Michal J Besser, Hinrich Abken, Dayana Blokon-Kogan, Maya Levi-Mann, Lior Malka-Levy, Yuval Shiftan, Gideon Gross, Hadas Weinstein-Marom
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Background Adoptive transfer of tumor-infiltrating lymphocytes (TILs) or blood T cells genetically redirected by an antitumor TCR or CAR induces a strong antitumor response in a proportion of patients with cancer; however, the therapeutic efficacy is
Externí odkaz:
https://doaj.org/article/5da24a6a92d74ac0a859adeb339173bd
Autor:
Dayana Blokon-Kogan, Maya Levi-Mann, Lior Malka-Levy, Orit Itzhaki, Michal J Besser, Yuval Shiftan, Árpád Szöőr, György Vereb, Gideon Gross, Hinrich Abken, Hadas Weinstein-Marom
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e001544
BackgroundAdoptive transfer of tumor-infiltrating lymphocytes (TILs) or blood T cells genetically redirected by an antitumor TCR or CAR induces a strong antitumor response in a proportion of patients with cancer; however, the therapeutic efficacy is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba5847fa7a11479388f0f941d788dd74
https://doi.org/10.1136/jitc-2020-001544
https://doi.org/10.1136/jitc-2020-001544
Autor:
Marlies S. Wijsenbeek, Jacobus Burggraaf, M.L. Lupher, D.M. Harper, Henk C. Hoogsteden, Alex KleinJan, John Getsy, Matthijs Moerland, M. G. J. van Dongen, Maya Levi, Marlous R. Dillingh, B. van den Blink
Publikováno v:
Pulmonary Pharmacology & Therapeutics, 26(6), 672-676. Academic Press
PRM-151, recombinant human Pentraxin-2 (PTX-2) also referred to as serum amyloid P (SAP), is under development for treatment of fibrosis. A First-in-Human (FIH) trial was performed to assess the safety, tolerability, and pharmacokinetics of single as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03521a80a96d9b1e724209870d462fb7
https://doi.org/10.1016/j.pupt.2013.01.008
https://doi.org/10.1016/j.pupt.2013.01.008
Autor:
Andrea Havasi, Cihan Heybeli, Nelson Leung, Avital Angel-Korman, Vaishali Sanchorawala, Oliver Cohen, Ashutosh Wechalekar, Frank Bridoux, Insara Jaffer, Victoria Gutgarts, Hani Hassoun, Maya Levinson, Cara Rosenbaum, Paolo Milani, Giovanni Palladini, Giampaolo Merlini, Ute Hegenbart, Stefan Schönland, Kaya Veelken, Alexander Pogrebinsky, Gheorghe Doros, Heather Landau
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 8, Pp 1-8 (2022)
Abstract Effective systemic therapies suppress toxic light chain production leading to an increased proportion of patients with light chain (AL) amyloidosis who survive longer albeit with end-stage renal disease. There is a critical need to identify
Externí odkaz:
https://doaj.org/article/8310aa42eeb54a7f8e5412643a28329a
Autor:
Tsaffrir Zor, Galit Levy-Rimler, Orna Ernst, Maya Levi, Bill Webb, Meir Goldsmith, Nathanael S. Gray, Dorit Avni, Hugh Rosen, Roi Mashiach, Michael M. Meijler
Publikováno v:
Immunology. 127:103-115
Tight regulation of the production of the key pro-inflammatory cytokine tumour necrosis factor-alpha (TNF-alpha) is essential for the prevention of chronic inflammatory diseases. In vivo administration of a synthetic phospholipid, named hereafter pho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::606dc0a33f3dae5314a3028528c722ca
https://doi.org/10.1111/j.1365-2567.2008.02928.x
https://doi.org/10.1111/j.1365-2567.2008.02928.x
Autor:
Jinxiu Rui, Songyan Deng, Ana Luisa Perdigoto, Gerald Ponath, Romy Kursawe, Nathan Lawlor, Tomokazu Sumida, Maya Levine-Ritterman, Michael L. Stitzel, David Pitt, Jun Lu, Kevan C. Herold
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
There are dynamic interactions between immune cells and β cells that lead to β cell destruction in the context of autoimmune diabetes. Here the authors show that TET2, a methylcytosine dioxygenase, can regulate this interaction and deletion of TET2
Externí odkaz:
https://doaj.org/article/d2099481cf7c45539fc5dd7688d09511
Publikováno v:
Molecular and Cellular Endocrinology
Molecular and Cellular Endocrinology, Elsevier, 2009, 314 (2), pp.248. ⟨10.1016/j.mce.2009.05.007⟩
Molecular and Cellular Endocrinology, Elsevier, 2009, 314 (2), pp.248. ⟨10.1016/j.mce.2009.05.007⟩
International audience; Ceramide-1-phosphate (C1P) is known as a second messenger regulating a multitude of processes including cell growth, apoptosis and inflammation. Exciting recent findings now suggest that C1P can stimulate macrophages migration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f423ca48a35772f6b96c9e19e45395d
https://hal.archives-ouvertes.fr/hal-00547652/file/PEER_stage2_10.1016%2Fj.mce.2009.05.007.pdf
https://hal.archives-ouvertes.fr/hal-00547652/file/PEER_stage2_10.1016%2Fj.mce.2009.05.007.pdf
Autor:
Kelly M. Gillen, Mayyan Mubarak, Calvin Park, Gerald Ponath, Shun Zhang, Alexey Dimov, Maya Levine‐Ritterman, Steven Toro, Weiyuan Huang, Stephanie Amici, Ulrike W. Kaunzner, Susan A. Gauthier, Mireia Guerau‐de‐Arellano, Yi Wang, Thanh D. Nguyen, David Pitt
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 8, Iss 4, Pp 877-886 (2021)
Abstract Background Inflammation in chronic active lesions occurs behind a closed blood–brain barrier and cannot be detected with MRI. Activated microglia are highly enriched for iron and can be visualized with quantitative susceptibility mapping (
Externí odkaz:
https://doaj.org/article/6e26628159d547dba32563ac9fe2dc94
Autor:
Calvin Park, Gerald Ponath, Maya Levine-Ritterman, Edward Bull, Eric C. Swanson, Philip L. De Jager, Benjamin M. Segal, David Pitt
Publikováno v:
Acta Neuropathologica Communications, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Activated myeloid cells and astrocytes are the predominant cell types in active multiple sclerosis (MS) lesions. Both cell types can adopt diverse functional states that play critical roles in lesion formation and resolution. In order to ide
Externí odkaz:
https://doaj.org/article/57a53454552d482c861ef8dccef5bf5d
Autor:
Krista J. Spiller, Tahiyana Khan, Myrna A. Dominique, Clark R. Restrepo, Dejania Cotton-Samuel, Maya Levitan, Paymaan Jafar-Nejad, Bin Zhang, Armand Soriano, Frank Rigo, John Q. Trojanowski, Virginia M.-Y. Lee
Publikováno v:
Neurobiology of Disease, Vol 124, Iss , Pp 133-140 (2019)
Therapeutic strategies are needed for the treatment of amyotrophic lateral sclerosis (ALS). One potential target is matrix metalloproteinase-9 (MMP-9), which is expressed only by fast motor neurons (MNs) that are selectively vulnerable to various ALS
Externí odkaz:
https://doaj.org/article/ec9d09c6684e4deaa96bf9bcd76793d2